Merck (NYSE: MRK), known outside the United States and Canada as MSD, today announced that the HPS2-THRIVE (Heart Protection Study ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE